Ultragenyx Pharmaceutical Net Foreign Currency Exchange Gain/Loss (Quarterly) Insights

Ultragenyx Pharmaceutical, Inc. (RARE)

34.35 -1.88 (-5.19%) USD | NASDAQ | Dec 16, 15:41

View Net Foreign Currency Exchange Gain/Loss (Quarterly) for RARE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	Upgrade
Geron Corp.	--
Vertex Pharmaceuticals, Inc.	--
Fortress Biotech, Inc.	--